Top

Reactions Weekly

Published in:

01-03-2023 | Chronic Lymphocytic Leukemia | Case report

Acalabrutinib/ibrutinib

Atrial fibrillation, complete heart block and bleeding : case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Ikram M, et al. SARCOID LYMPHOMA SYNDROME: THE DISCOVERY OF CARDIAC SARCOIDOSIS DURING THERAPY FOR CHRONIC LYMPHOCYTIC LEUKEMIA, SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL). Journal of the American College of Cardiology 81 (Suppl.): 2971 (plus poster) abstr. 1346-109, No. 8, et al. Mar 2023. Available from: URL: http://doi.org/10.1016/S0735-1097%2823%2903415-0 [abstract]

Title: Acalabrutinib/ibrutinib
Atrial fibrillation, complete heart block and bleeding : case report
Publication date: 01-03-2023
Publisher: Springer International Publishing
Keywords: Chronic Lymphocytic Leukemia
Sarcoidosis
Sarcoidosis
Atrial Fibrillation
Conventional Pacemaker
Conventional Pacemaker
Acalabrutinib
Ibrutinib
Pacemaker
Pacemaker
Pacemaker
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-35996-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Acalabrutinib/ibrutinib

Atrial fibrillation, complete heart block and bleeding : case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Heparin

Multiple drugs

Nivolumab/pembrolizumab

Chlorhexidine/tetracaine/chlorhexidine

Multiple drugs

Severe-acute-respiratory-syndrome-coronavirus-2-mRNA-vaccine